FDA Expands New Treatment for Metastatic Prostate Cancer: Targets a Protein Called PSMA

Memorial Sloan Kettering Cancer Center·May 20

This story is reported by Memorial Sloan Kettering Cancer Center. Read what other outlets are saying below, then open the original report for full details.